A new study published in The Lancet, one of the world’s oldest and most highly regarded peer-reviewed medical journals, suggests that smokers given higher-nicotine vaping products consume fewer dangerous carcinogens through continued smoking compared with their peers given lower-strength vapes.

The study—funded by the National Institutes of Health (NIH) and the Food and Drug Administration (FDA)—looked at how smokers’ use of electronic nicotine delivery systems (ENDS) could help them cut back on cigarettes.

The participants, aged from 21 to 65, had smoked more than nine cigarettes per day for at least the past year and were not currently using ENDS. They then received either a cartomizer-based, pen-style ENDS paired with 0, 8, or 36 mg/mL liquid nicotine, or—for the control group—a cigarette-shaped plastic tube that did not deliver any nicotine or aerosol. Over the course of 24 weeks, all groups were instructed to reduce their cigarette consumption first by 50 percent, and then by 75 percent.

Read full article here.

Alex Norcia – FilterMag – 2021-04-22.

Want More Investigative Content?

LEAVE A REPLY

Please enter your comment!
Please enter your name here